US Broker Ratings

Align Technology, Inc. (ALGN) Stock Analysis: Navigating a 26.61% Potential Upside Amidst Market Challenges

Align Technology, Inc. (NASDAQ: ALGN) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Known for its innovative Invisalign..

Cardinal Health, Inc. (CAH) Stock Analysis: Evaluating Growth Prospects and Performance in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, has been capturing investor attention with its robust market presence and strategic initiatives. With..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 14.61% Upside Potential in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, BeOne Medicines Ltd. (ONC) presents an intriguing prospect. Based in Switzerland, this oncology-focused biopharmaceutical company is making waves..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Uncovering a Potential 11.65% Upside in the Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the medical devices industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector...

Agilent Technologies, Inc. (A) Stock Analysis: A Healthcare Giant with a Promising Target Price

Agilent Technologies, Inc. (NYSE: A), a powerhouse in the healthcare sector’s diagnostics and research industry, continues to capture investor attention with its strong market presence and..

Koninklijke Philips N.V. (PHG) Stock Analysis: A 24% Potential Upside with Strong Buy Ratings

Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the healthcare sector, is capturing investor attention with its promising potential upside of 24.08%. As a global..

Haleon plc (HLN) Stock Analysis: Unpacking a 16.80% Potential Upside

Haleon plc (HLN), a prominent player in the healthcare sector, stands out with its diverse portfolio of consumer healthcare products. As a key figure in the..

Abbott Laboratories (ABT) Stock Analysis: Strong Buy Ratings and a 13% Upside Potential

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor interest with its robust market position and promising growth prospects. With a..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 39% Potential Upside in the Animal Health Sector

Zoetis Inc. (NYSE: ZTS), a prominent player in the healthcare sector, stands out as a leading drug manufacturer specializing in both specialty and generic animal health..

Eli Lilly (LLY) Investor Outlook: A Healthcare Giant with Impressive Revenue Growth and Robust Analyst Confidence

Eli Lilly and Company (NYSE: LLY) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. With a staggering market capitalization..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring a 3.31% Potential Upside Amid Robust Drug Portfolio

Gilead Sciences, Inc. (NASDAQ: GILD), a powerhouse in the biopharmaceutical sector, is currently trading at $126.64, with its stock price change sitting at a modest 0.01%..

Pfizer, Inc. (PFE) Investor Outlook: Analyzing a Promising 15.64% Potential Upside

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector, offers a compelling narrative for investors seeking stability combined with growth potential. With a market capitalization..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 10% Upside Potential in the Healthcare Sector

IQVIA Holdings, Inc. (NYSE: IQV) stands out in the healthcare industry with a market capitalization of $38.3 billion, positioning itself as a key player in the..

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating a 29.78% Potential Upside in the Healthcare Software Sector

Veeva Systems Inc. (NYSE: VEEV), a leading provider of cloud-based solutions for the life sciences industry, presents a compelling investment opportunity with a notable potential upside..

CVS Health Corporation (CVS) Stock Analysis: Evaluating a 17.24% Potential Upside Amid Strong Buy Ratings

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector, a segment increasingly critical in today’s evolving market landscape. With a robust..

GSK plc (GSK) Stock Analysis: Evaluating the Healthcare Giant’s Modest Upside Potential

GSK plc (NYSE: GSK), a prominent name in the healthcare sector, has drawn investor attention with its robust portfolio in vaccines and specialty medicines. Despite its..

Stryker Corporation (SYK) Stock Analysis: Exploring a 16.48% Potential Upside and Strong Revenue Growth

Stryker Corporation (NYSE: SYK), a stalwart in the healthcare sector, commands attention with its robust market capitalization of $140.84 billion. As a leading player in the..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 20.86% Potential Upside for Investors

UnitedHealth Group Incorporated (NYSE: UNH) is a formidable player in the healthcare sector, with a market capitalization of $289.84 billion. Operating across a broad spectrum of..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating the Healthcare Giant’s Growth and Dividend Potential

Johnson & Johnson (JNJ) stands as a towering figure in the healthcare sector, commanding a market capitalization of $491.26 billion. With a diverse portfolio spanning pharmaceuticals,..

Kamada Ltd. (KMDA) Investor Outlook: A 120% Upside Potential Beckons in the Biopharma Sector

For investors keen on exploring opportunities within the healthcare sector, Kamada Ltd. (NASDAQ: KMDA) presents an intriguing proposition. Specializing in the manufacture and sale of plasma-derived..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds